Replies to post #17065 on Biostax Corp (BTAX)

[Ahjon81]

$IMUN $CBLI 4Q2020- 1Q2021 potential milestone:
Phase 2 covid 19 trial to recruit patients with Mild/Moderate disease. The trial to start 12/2020 ($3B-5B)
Phase 3 trial Crohn disease to start in 1Q2021 ($12B market size). #Pennystocks #OTCSTOCKS #Covid19 $ibio https://t.co/5XYQxvzszH

[Yak]

Great to hear something. Thank you